Fracture risk assessment of men treated with androgen deprivation therapy for prostate cancer

被引：0
|
作者：
Turo, R. [1 ]
Smolski, M. [2 ]
Das, S. [1 ]
Awsare, N. S. [1 ]
Pettersson, B. A. [1 ]
Adeyoju, A. [3 ]
Bromage, S. J. [3 ]
Brown, S. C. W. [3 ]
Brough, R. [3 ]
Collins, G. N. [3 ]
机构：
[1] Countess Chester Hosp, Dept Urol, Chester, Cheshire, England
[2] Royal Preston Hosp, Dept Urol, Preston, Lancs, England
[3] Stepping Hill Hosp, Dept Urol, Stockport, Lancs, England
来源：
BJU INTERNATIONAL | 2016年 / 118卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
20
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [31] Risk of fracture after androgen deprivation for prostate cancer
    Shahinian, VB
    Kuo, Y
    Freeman, JL
    Goodwin, JS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (02): : 154 - 164
  • [32] Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer
    Liu, Jui-Ming
    Shen, Chin-Yao
    Lau, Wallis C. Y.
    Shao, Shih-Chieh
    Man, Kenneth K. C.
    Hsu, Ren-Jun
    Wu, Chun-Te
    Lai, Edward Chia-Cheng
    [J]. CANCERS, 2021, 13 (15)
  • [33] EVALUATING CARDIOVASCULAR RISK IN MEN STARTING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
    Lowentritt, Benjamin
    Fallick, Mark
    Dufour, Robert
    Pruett, Janis
    Jiang, Tao
    Nwokeji, Esmond
    Nagao, Mitch
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E821 - E821
  • [34] Androgen-deprivation Therapy and Risk for Biliary Disease in Men with Prostate Cancer
    Saylor, Philip J.
    Smith, Matthew R.
    O'Malley, A. James
    Keating, Nancy L.
    [J]. EUROPEAN UROLOGY, 2014, 65 (03) : 642 - 649
  • [35] Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy
    O'Farrell, Sean
    Sandstrom, Karin
    Garmo, Hans
    Stattin, Par
    Holmberg, Lars
    Adolfsson, Jan
    Van Hemelrijck, Mieke
    [J]. BJU INTERNATIONAL, 2016, 118 (03) : 391 - 398
  • [36] Assessment and management of fracture risk in men with prostate cancer taking androgen deprivation therapy: a retrospective observational primary care database study
    Huang, Qizhi
    Brown, Janet
    Mitchell, Caroline
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2024, 74
  • [37] Simple risk assessment in prostate cancer patients treated with primary androgen deprivation therapy: The Korean Cancer Study of the Prostate risk classification
    Choi, Se Young
    Ryu, Jeman
    You, Dalsan
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (01) : 62 - 68
  • [38] Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States
    Beebe-Dimmer, Jennifer L.
    Cetin, Karynsa
    Shahinian, Vahakn
    Morgenstern, Hal
    Yee, Cecilia
    Schwartz, Kendra L.
    Acquavella, John
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (01) : 70 - 78
  • [39] Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy
    Wu, Szu-Yuan
    Fang, Su-Chen
    Shih, Hung-Jen
    Wen, Yu-Chin
    Shao, Yu-Hsuan Joni
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 112 : 109 - 117
  • [40] Maximal Exercise Testing of Men with Prostate Cancer Being Treated with Androgen Deprivation Therapy
    Wall, Bradley A.
    Galvao, Daniel A.
    Fatehee, Naeem
    Taaffe, Dennis R.
    Spry, Nigel
    Joseph, David
    Newton, Robert U.
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2014, 46 (12): : 2210 - 2215
12345